were produced by Dolichothele sphaerica.
INTRODUCTION
UNNATURAL or aberrant alkaloids are analogs of naturally occurring alkaloids that are produced when unnatural compounds, closely related to the natural precursors, are introduced into plants.
The cactus Dolichothele sphaerica yields a novel imidazole alkaloid named dolichotheline (IV-isovalerylhistamine)
(1). Is2 This monosubstituted amide appears to arise biosynthetically by means of a mechanism involving the condensation of histamine and isovaleric acid.3 The cactus was then considered suitable for carrying out experiments to determine whether the enzyme(s) responsible for this linkage could also yield aberrant alkaloids following the administration of selected precursors to the plant. Preliminary studies on the production of unnatural analogs of dolichotheline resulted in the formation of two aberrant alkaloidq4 4(S)- [N -isovalerylaminomethyl] imidazole (2) following the administration of 4(.5)-aminomethylimidazole to the plant and N-isocaproylhistamine (3) following the administration of isocaproic acid.
All studies on the production of aberrant alkaloids have been limited to the biosynthetic conversion of a structurally modified, single, precursor into a correspondingly modified unnatural alkaloid.5p9 The objectives of our current investigation were 2-fold: (a) to test the simultaneous administration of two unnatural precursors, namely isocaproic 
RESULTS

AND DISCUSSION
Since the quantities of the expected unnatural alkaloids were small, authentic samples of the required dolichotheline analogs were synthesized to serve both as standards and as carriers during the extraction procedure. All precursors were aseptically injected into the cactus plants. The radioactive analogs were separated from dolichotheline by preparative TLC, recrystallized to constant specific activity. a single derivative prepared as a further check of the radiopurity, and degraded to localize the label.
The data obtained from in GPO studies on the production of aberrant alkaloids are summarized in Table I as dolichotheline analog are based on the 500 mg of the analog added as carrier. Since the actual amount of analog formed is less than 1 mg, the error made in calculating percent incorporation based on a total yield of 500 mg is very small. The isolated alkaloid 4, when benzoylated, yielded nearly inactive l,Zdibenzoylamino-3-isocaproylaminopropene-1.
This degradation showed that greater than 99% of the activity resided in the predicted position.
When 5 obtained from plants injected with isovaleric acid-[l-'4C] and 3-aminoethylpyrazole was hydrolyzed, the activity resided in the isovalerate portion of the molecule. Decarboxylation by the Schmidt reaction provided carbonate which contained greater than 96% of the activity present in the isovaleric acid. The remaining isobutylamine, isolated as isobutylphenylthiourea, was essentially inactive. It is interesting to note the large percent incorporation obtained when 4(5)-aminomethylimidazole and isocaproic acid were used in combination as compared to when they were introduced separately (1.27 and @81x respectively).4 Perhaps both the amine and acid precursors must be present in sufficient quantity to promote or induce the activity of the enzyme(s) involved.
The positive result obtained with Saminoethylpyrazole as the precursor suggests the possibility that other properly substituted heterocyclic nuclei, such as thiazoles and triazoles, could prove to be successful precursors also.
The present study indicates the versatility of the enzyme system that catalyzes the condensation of histamine and isovaleric acid. It also illustrates two previously unreported techniques relative to the production of aberrant alkaloids in higher plants. These include the simultaneous incorporation of two unnatural precursors into an unnatural alkaloid and the incorporation of a heterocyclic entity. completely different from the natural precursor, into its corresponding unnatural alkaloid. In addition, the present investigation points out the potential application of the techniques utilized in the preparation of analogs of biologically active natural products that are difficult to synthesize. Furthermore, such experimentation can reveal the specificity of enzymes involved in the biosynthesis of natural products in cases when these enzymes may not. for technical reasons, be accessible for study in the free state. 
4(5)-[,2'-Isocaproylaminomethyl]-imidazolc (4). 4(j)-i\minomethyl-
imidazole was synthesized under condiiions prcviouslq reported." This amine (I g) and 4-methylvaleryl chloride (1.5 g) were retluxed gently for 20 min. The reaction mixture wab then cooled. dissolved in 10 ml I M fIC1, and extracted with Et,0 ( x 3). The aq. soln K~S made alkallnc ulth coni '\;lH,OW to pfl 0. appropriate nonradioactive dolichotheline analog was added to the ground material. The method used for the extraction and isolation of dolichotheline and its unnatural analogs was identical to that previously reported for the isolation of dolichotheline. ' Any radioactivity residing in the unnatural analogs was monitored using TLC and radiochromatogram scanning. The radioactive analogs were separated from dolichotheline by preparative TLC. Separation of 4 from dolichotheline. A mixture (637 mg) of 4 and dolichotheline was dissolved in a small vol. MeOH and applied (100 mg/plate) to a 2 mm layer of silica gel GFZ5,, 20 x 20 cm plates. The plates were then subjected to multiple development (x 3) in CHCl,-EtOH-1 M HCl (8 : 2 : 0.1). The R, for dolichotheline was 0.39; for 4, it was 0.61. The silica gel scraped off the plates was extracted with MeOH (3 x 100 ml). The MeOH extract was reduced to dryness and dissolved in 15 ml H,O; the pH was adjusted to 9.5 with cont. NH,OH, and the soln was extracted with hot CHCI, in a liquid-liquid extractor for 24 hr. The CHCl, extract was dried and evaporated to yield 211 mg of 4, m.p. 123-124".
Separation of5fiom dolichothehe.
A mixture (600 mg) of 5 and dolichotheline was separated by a method similar to that employed for the separation of 4 and dolichotheline. The preparative plates in this case were developed 2 x using the above solvent system. The R, for dolichotheline was 0.25; for 5, it was 0.68. The CHCIJ extract when evaporated yielded a syrupy residue of 5 which was converted to the picrate, m.p. 136". Degradation of4 (Scheme2). The amide (200 mg) was added to a cold soln of 1 g NaOH in 5 ml H20.
This was followed by the addition of 0.5 ml PhCOCl and 2 drops CsH, The mixture was stirred vigorously for 2 hr with cooling, after which the solid product was filtered, washed with a little H,O, and dried. 
Degradation of 5 (Scheme 3). S was hydrolyzed
with 10% HCl, and the resulting 4(5)-aminoethylpyrazole and isovalerate were recovered as the dihydrochloride and sodium salts, respectively, by identical procedures described for the hydrolysis of dolichotheline.3
The sodium isovalerate was further degraded by means of a Schmidt decarboxylation essentially as described by Phares. I3 The sodium isovalerate and NaCl mixture (300 mg) was dissolved in cold 100% H,SO, (3 ml) in a 25 ml pear-shaped flask and powdered NaN, (250 mg) was added in small amounts, with shaking, to the chilled soln. The flask was immediately connected to two bead towers in series, the first containing 10 ml 5% KMnO, in 0.5 M H,SO, and the second containing 10 ml 1 M CO,-free NaOH. A slow stream of N, was forced through the solution while the flask was heated to 60-65" for 6 hr. The bead tower containing the NaOH was then washed down with CO,-free H,O, and 2 ml satd. BaCI, was added. The resulting precipitate was centrifuged and the supernate was decanted. The BaCO, was resuspended in H,O and again centrifuged. This process was repeated with EtOH and the carbonate was finally dried in a desiccator.
To recover the isobutylamine, the contents of the reaction flask were basified to pH 12 with 207" NaOH and the isobutylamine was extracted 3 x with equal portions of Et,O. The isobutylamine was then reacted with phenylisothiocyanate to form isobutylphenylthiourea.'* Radioactiue assay. The method employed for the preparation of samples for scintillation counting was described previously. 15.16 The aberrant products were recrystallized to constant sp. act., and a single derivative of each product was also counted as a check of the radiopurity.
The two degradation products were assayed to localize the label. The BaCO, (@5 mg) was assayed as a suspension in scintillation fluid containing a thixotropic gel (5 g Cab-O-Sil/l,OOO ml of scintillation cocktail). All samples were counted in a liquid scintillation system at a preset 20 statistical counting error of lyV The external standard ratio method was used to determine losses due to quenching. All counts were corrected for counter efficiency.
